Psychiatry's Biggest Mistake? | Dr Kris Kaliebe

28 May 2026

With Dr Kristopher Kaliebe

North America

Dr Kristopher Kaliebe, a forensic and child psychiatrist from the University of South Florida, examines how psychiatry traded psychoanalytic nuance for biological reductionism — and how that same error has entrenched "born in the wrong body" as unquestionable clinical fact. His analysis echoes the findings of the Cass Review, which concluded that gender-affirmative protocols in the UK were built on inadequate evidence. A US forensic psychiatrist's account of institutional failure, read alongside NHS England's restructuring of paediatric gender services, illuminates a shared collapse of professional scepticism.

Dr Kristopher Kaliebe is a Professor of Psychiatry at the University of South Florida with specialist certification in child, adolescent and forensic psychiatry. In this conversation he traces a long arc of professional failure — from psychiatry's abandonment of psychoanalytic complexity in favour of biological reductionism, through the pharmaceutical industry's colonisation of diagnostic thinking, to the clinical moment at which the phrase "born in the wrong body" was allowed to pass as a medical fact. The parallel Kaliebe draws is precise and uncomfortable. The same epistemological error that gave the world "chemical imbalance in the brain" as an explanation for depression — a simplification that was useful as metaphor, then catastrophic when taken literally — has been reproduced in gender medicine. A culturally driven narrative about identity became encoded in clinical language, and the institutions that should have scrutinised it instead amplified it. Kaliebe argues this is not an accident but a pattern: psychiatry has repeatedly mistaken social consensus for scientific evidence. In the United Kingdom, that pattern has now been formally acknowledged. The Cass Review, published in April 2024, found that the evidence base underpinning paediatric gender medicine was of remarkably low quality, that affirmative approaches had been adopted without adequate clinical scrutiny, and that a generation of young people had been assessed and treated under protocols that would not have passed muster in any comparable area of medicine. NHS England subsequently closed the Tavistock GIDS and introduced new interim clinical guidance restricting puberty blockers outside research settings. What Kaliebe describes as a systemic failure of institutional scepticism maps directly onto what the Cass Review identified as a field that had moved faster than the evidence could support. The concept of extreme overvalued belief runs through this episode as a clinical frame for understanding why some young people hold their gender convictions with such intensity — and why those convictions have so often been treated as sacrosanct rather than explored therapeutically. This is territory with direct relevance to UK clinical practice, where revised NHS guidance now asks clinicians to consider the full psychological and developmental picture of a young person rather than treating a stated identity as the conclusion of assessment. Kaliebe also addresses the US Department of Health and Human Services report on gender dysphoria, which reached conclusions broadly consistent with the Cass Review and the systematic reviews published in Sweden, Finland and Denmark: the evidence for medical interventions in minors is insufficient to support routine clinical use. Taken together, these reviews represent a convergence of expert scepticism across jurisdictions that professional bodies can no longer easily dismiss. For anyone following the evidence as it accumulates in courts, clinics and public inquiries, this conversation offers a forensically trained psychiatrist's account of how the field got here — and what honest course-correction would require.

The dossier behind this episode